The Challenge of Stroke Prevention

JAMA

Volumn 291, Issue 5, 2004, Pages 621-622

  Hanley, Daniel F ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PHOSPHOLIPID ANTIBODY; PYRIDOXINE; WARFARIN;

AGING; BLOOD PRESSURE REGULATION; BRAIN BLOOD VESSEL; CLINICAL TRIAL; DRUG EFFECT; DRUG MEGADOSE; EDITORIAL; EXERCISE; HUMAN; HYPERHOMOCYSTEINEMIA; PRIORITY JOURNAL; RECURRENT DISEASE; RISK REDUCTION; SMOKING CESSATION; STROKE; THROMBOSIS; VITAMIN INTAKE; BLOOD; CEREBROVASCULAR ACCIDENT; NOTE; RISK FACTOR;

ANTIBODIES, ANTIPHOSPHOLIPID; CEREBROVASCULAR ACCIDENT; FOLIC ACID; HOMOCYSTEINE; HUMANS; RISK FACTORS; RISK REDUCTION BEHAVIOR; VITAMIN B 12; VITAMIN B 6;

EID: 1342309944     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.291.5.621     Document Type: Editorial

References (11)

1. Elkins JS, Johnston SC. Thirty-year projections for deaths from ischemic stroke in the United States. Stroke. 2003;34:2109-2112.
2. 6 on clinical outcome after percutaneous coronary intervention. JAMA. 2002;288:973-979.
3. Toole JF, Malinow MR, Chambless LE, et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA. 2004;291:565-575.
4. Gorelick PB, Sacco RL, Smith DB, et al. Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Association. JAMA. 1999;281:1112-1120.
5. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358:1033-1041.
6. Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000;342:145-153.
7. Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ. 2003;326:1423.
8. Macko RF, Smith GV, Dobrovolny CL, Sorkin JD, Goldberg AP, Silver KH. Treadmill training improves fitness reserve in chronic stroke patients. Arch Phys Med Rehabil. 2001;82:879-884.
9. APASS Investigators. Antiphospholipid antibodies and subsequent thromboocclusive events in patients with ischemic stroke. JAMA. 2004;291:576-584.
10. Wilson WA, Gharavi AE, Piette J-C. International classification criteria for antiphospholipid syndrome: synopsis of a post-conference workshop held at the Ninth International (Tours) aPL Symposium. Lupus. 2001;10:457-460.
11. Gorelick PB, Alter M. The Prevention of Stroke. Boca Raton, Fla: CRC Press; 2002.